a close up of a flower

Machine Learning for Cancer Immunotherapy

出版物

表示方法:

- Multifactorial Model to Predict Response to PD-(L)1 Blockade in Patients with High PD-L1 Metastatic Non-Small Cell Lung Cancer
  
  K. Arbour, Miruna Oprescu, J. Hakim, H. Rizvi, M. Leiserson, M. Ginsburg, A. Plodkowski, J. Sauter, I. Preeshagul, Sharon Gillett, Philip Rosenfield, Lester Mackey, Miro Dudík, M. Hellmann
  
  Journal of Thoracic Oncology | October 2019, 巻14(10): pp. S290
  
  Publication DOI
- A Multifactorial Model of T Cell Expansion and Durable Clinical Benefit in Response to a PD-L1 Inhibitor
  
  Mark DM Leiserson, Vasilis Syrgkanis, Amy Gilson, Miroslav Dudik, Sharon Gillett, Jennifer Chayes, Christian Borgs, Dean F. Bajorin, Jonathan Rosenberg, Samuel Funt, Alexandra Snyder, Lester Mackey
  
  PLOS ONE | December 2018, 巻13(12): pp. 1-11
  
  Publication DOI PDF

- Multifactorial Model to Predict Response to PD-(L)1 Blockade in Patients with High PD-L1 Metastatic Non-Small Cell Lung Cancer
  
  K. Arbour, Miruna Oprescu, J. Hakim, H. Rizvi, M. Leiserson, M. Ginsburg, A. Plodkowski, J. Sauter, I. Preeshagul, Sharon Gillett, Philip Rosenfield, Lester Mackey, Miro Dudík, M. Hellmann
  
  Journal of Thoracic Oncology | October 2019, 巻14(10): pp. S290
  
  Publication DOI
- A Multifactorial Model of T Cell Expansion and Durable Clinical Benefit in Response to a PD-L1 Inhibitor
  
  Mark DM Leiserson, Vasilis Syrgkanis, Amy Gilson, Miroslav Dudik, Sharon Gillett, Jennifer Chayes, Christian Borgs, Dean F. Bajorin, Jonathan Rosenberg, Samuel Funt, Alexandra Snyder, Lester Mackey
  
  PLOS ONE | December 2018, 巻13(12): pp. 1-11
  
  Publication DOI PDF

- Multifactorial Model to Predict Response to PD-(L)1 Blockade in Patients with High PD-L1 Metastatic Non-Small Cell Lung Cancer
  
  K. Arbour, Miruna Oprescu, J. Hakim, H. Rizvi, M. Leiserson, M. Ginsburg, A. Plodkowski, J. Sauter, I. Preeshagul, Sharon Gillett, Philip Rosenfield, Lester Mackey, Miro Dudík, M. Hellmann
  
  Journal of Thoracic Oncology | October 2019, 巻14(10): pp. S290
  
  Publication DOI
- A Multifactorial Model of T Cell Expansion and Durable Clinical Benefit in Response to a PD-L1 Inhibitor
  
  Mark DM Leiserson, Vasilis Syrgkanis, Amy Gilson, Miroslav Dudik, Sharon Gillett, Jennifer Chayes, Christian Borgs, Dean F. Bajorin, Jonathan Rosenberg, Samuel Funt, Alexandra Snyder, Lester Mackey
  
  PLOS ONE | December 2018, 巻13(12): pp. 1-11
  
  Publication DOI PDF

人数

Research Team

Miro Dudík

Sr Principal Researcher Manager

詳細はこちら

Lester Mackey

Senior Principal Researcher

詳細はこちら

Govinda Kamathの肖像

Govinda Kamath

Postdoctoral Researcher

Max Leisersonの肖像

Max Leiserson

Consulting Researcher

University of Maryland

詳細はこちら

Sharon Gillett

Technical Advisor and Sr. Principal Research Program Manager

詳細はこちら

Philip Rosenfield

Director, Research Strategy Health and Life Sciences

詳細はこちら

Ernest Fraenkel

Consulting Researcher

MIT

詳細はこちら

Hugh Yehの肖像

Hugh Yeh

Research Assistant

Previous Contributors

Joe Hakimの肖像

Joe Hakim

Research Assistant

Amy Gilsonの肖像

Amy Gilson

Research Program Manager

詳細はこちら

Francesco Paolo Casaleの肖像

Francesco Paolo Casale

Postdoctoral Researcher